Replies to post #122947 on Innovation Pharmaceuticals Inc (IPIX)

[Loose Lips]

Well said.

[BooDog]

Certainly no shortage of information. Compared to many other companies Cellceutix does extremely well in keeping the base informed. Just a matter of being patient and keeping a grip on what really matters.
Considering the attempt for a shake out Cellceutix held up very nicely. 1.61 - 1.71. Not bad on a day like today.

[58nout]

Great post. Even with all of this, the uninformed disparage this progress.

GO CTIX

[incubus-now]

Sometimes facts just don't get through.
Good job putting them together.

[DaubersUP]

This is a favorite:
08/07/15 Cellceutix Provides Insights to its Four Clinical Trials for the Treatment of ABSSSI (Completed Phase 2), Anti-Cancer (Phase 1), Psoriasis (Phase 2), and Oral Mucositis in Head and Neck Cancer Patients (Phase 2)


I mean....HELLLLLOOOOOOOO$$$$$$$$$$$$$$$$$. :)

[Pepperchino]

Wow, this should be a sticky IMO! I'm at least going to copy it myself. Long way this company has come from animal studies to 6 human trials completed or ongoing! Go Leo!!

[WILD_4_IPIX]

TREMENDOUS POST ! Thanks RULE !

GO CTIX !

[Phoenix300]

Nice post! Look out for two more PR's coming....

Kevetrin Phase 1 Trial has been Successfully Completed

Brilacidin Phase 3 ABSSI Trial has begun.

I could add a few more but those are only after these two have been released. Hahahahahahhaahhahah

[farrell90]

Impressive list! Politicians should study the list for some insight into the grueling process companies have to endure in order to prove their pharmaceuticals are safe and effective.

Thanks for posting, Farrell

[Snowy_Owl]

Great post RR. Seeing the 5+ year history of CTIX PRs refreshed my memory of why I'm still long and strong today.

It feels good to be sitting in the Catbird seat. Patiently sittin' on my pile of shares.

[To infinity and beyond!]

Not to mention the following future pr's:

Next to last patient has completed enrollment in Kevetrin Phase 1 trial

Final patient completes enrollment in Kevetrin Phase 1 trial

CTIX announces a guess when the Bologna AML trial will begin: we announced it was starting soon about a year ago, so who knows really. We don't know- the country is just getting back from vacation and returning to work. So submit your guess and one day, sometime in the next year or two , maybe, we shall see. Guesses may be sumitted directly at Beverly office- we promise someone will be there to answer the door- it's not empty as some nefarious individuals suggest

Cellceutix announces possible upcoming discussions with FDA about Hidradenitis Suppurativa. Just wait until we know more about Brilacidin OM, even though earlier we were going to meet with them anyway. It is now on a back burner. But at least it's on a burner.

CTIX announces potential jackpot indication for ulcerative proctitis, but only once more is known about Brilacidin OM, which will take a long time. But maybe at some future point it will be a big winner for us and proctitis sufferers. Also on the back burner.

CTIX says the new gram negative drug 1807 might fit on the stove but burners are crowded.

CTIX says it will re-release previous old favorite PR's. Look we just re-released the Brilacidin hip joint materials announcement. Let us know what other your other favorites are and we will consider them for regifting. The disappearing spleen lesion? They're all on the table, get in line.